Canaccord Genuity Starts Ultragenyx Pharma (RARE) at Buy
Tweet
Share
E-mailGet Alerts RARE Hot Sheet
Price: $42.37 -2.33%
Rating Summary:
19 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
19 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
Canaccord Genuity initiated coverage on Ultragenyx Pharma (NASDAQ: RARE) with a Buy rating and a price target of $60.00.
For an analyst ratings summary and ratings history on Ultragenyx Pharma click here. For more ratings news on Ultragenyx Pharma click here.
Shares of Ultragenyx Pharma closed at $48.65 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Loop Capital Starts DoorDash Inc. (DASH) at Buy, 'Category Killer with Stellar Execution'
- Piper Sandler Reiterates Overweight Rating on Ultragenyx Pharma (RARE)
- B.Riley Resumes QuinStreet, Inc. (QNST) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
